{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:35:31Z","timestamp":1762252531019,"version":"3.40.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T00:00:00Z","timestamp":1492819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T00:00:00Z","timestamp":1492819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00430-017-0507-0","type":"journal-article","created":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T06:58:08Z","timestamp":1492844288000},"page":"301-309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Phage-displayed peptides that mimic epitopes of hepatitis E virus capsid"],"prefix":"10.1007","volume":"206","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6838-5494","authenticated-orcid":false,"given":"Osmany","family":"Larralde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juraj","family":"Petrik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,22]]},"reference":[{"key":"507_CR1","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/jmv.21147","volume":"80","author":"L Rodr\u0131guez-Lay","year":"2008","unstructured":"Rodr\u0131guez-Lay L, Quintana A, Montalvo-Villalba MC et al (2008) Dual infection with hepatitis A and E viruses in outbreaks and in sporadic clinical cases: Cuba 1998\u20132003. J Med Virol 80:798\u2013802. doi:10.1002\/jmv.21147","journal-title":"J Med Virol"},{"key":"507_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/jmv.20324","volume":"76","author":"A Quintana","year":"2005","unstructured":"Quintana A, Sanchez L, Larralde O, Anderson D (2005) Prevalence of antibodies to hepatitis E virus in residents of a district in Havana, Cuba. J Med Virol 76:69\u201370. doi:10.1002\/jmv.20324","journal-title":"J Med Virol"},{"key":"507_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4142\/jvs.2016.17.1.1","volume":"17","author":"WJ Park","year":"2016","unstructured":"Park WJ, Park BJ, Ahn HS et al (2016) Hepatitis E virus as an emerging zoonotic pathogen. J Vet Sci 17:1\u201311. doi:10.4142\/jvs.2016.17.1.1","journal-title":"J Vet Sci"},{"key":"507_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000357098","volume":"41","author":"J Dreier","year":"2014","unstructured":"Dreier J, Juhl D (2014) Autochthonous hepatitis e virus infections: a new transfusion-associated risk? Transfus Med hemotherapy 41:29\u201339. doi:10.1159\/000357098","journal-title":"Transfus Med hemotherapy"},{"key":"507_CR5","first-page":"103","volume":"50","author":"Health Protection Scotland","year":"2016","unstructured":"Health Protection Scotland (2016) Hepatitis E. HPS Wkly Rep 50:103\u2013107","journal-title":"HPS Wkly Rep"},{"key":"507_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/vox.12285","volume":"110","author":"J Petrik","year":"2016","unstructured":"Petrik J, Lozano M, Seed CR et al (2016) Hepatitis E. Vox Sang 110:93\u2013130. doi:10.1111\/vox.12285","journal-title":"Vox Sang"},{"key":"507_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00430-016-0484-8","volume":"206","author":"J Teixeira","year":"2017","unstructured":"Teixeira J, Mesquita JR, Pereira SS et al (2017) Prevalence of hepatitis E virus antibodies in workers occupationally exposed to swine in Portugal. Med Microbiol Immunol 206:1\u20135. doi:10.1007\/s00430-016-0484-8","journal-title":"Med Microbiol Immunol"},{"key":"507_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00430-014-0336-3","volume":"203","author":"A Krumbholz","year":"2014","unstructured":"Krumbholz A, Joel S, Dremsek P et al (2014) Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany. Med Microbiol Immunol 203:273\u2013282. doi:10.1007\/s00430-014-0336-3","journal-title":"Med Microbiol Immunol"},{"key":"507_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00430-011-0218-x","volume":"201","author":"C Reinheimer","year":"2012","unstructured":"Reinheimer C, Allwinn R, Berger A (2012) Hepatitis E: are psychiatric patients on special risk? Med Microbiol Immunol 201:171\u2013175. doi:10.1007\/s00430-011-0218-x","journal-title":"Med Microbiol Immunol"},{"key":"507_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3201\/eid1902.121174","volume":"19","author":"BA Payne","year":"2013","unstructured":"Payne BA, Medhi M, Ijaz S et al (2013) Hepatitis E virus seroprevalence among men who have sex with men, United Kingdom. Emerg Infect Dis 19:333\u2013335. doi:10.3201\/eid1902.121174","journal-title":"Emerg Infect Dis"},{"key":"507_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1586\/14787210.2015.981158","volume":"13","author":"BL Kmush","year":"2015","unstructured":"Kmush BL, Nelson KE, Labrique AB (2015) Risk factors for hepatitis E virus infection and disease. Expert Rev Anti Infect Ther 13:41\u201353. doi:10.1586\/14787210.2015.981158","journal-title":"Expert Rev Anti Infect Ther"},{"key":"507_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(14)61034-5","volume":"6736","author":"PE Hewitt","year":"2014","unstructured":"Hewitt PE, Ijaz S, Brailsford SR et al (2014) Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 6736:1\u20138. doi:10.1016\/S0140-6736(14)61034-5","journal-title":"Lancet"},{"key":"507_CR13","doi-asserted-by":"publisher","first-page":"7030","DOI":"10.3748\/wjg.v22.i31.7030","volume":"22","author":"MS Khuroo","year":"2016","unstructured":"Khuroo MS, Khuroo MS, Khuroo NS (2016) Hepatitis E: discovery, global impact, control and cure. World J Gastroenterol 22:7030\u20137045. doi:10.3748\/wjg.v22.i31.7030","journal-title":"World J Gastroenterol"},{"key":"507_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3201\/eid1702.100856","volume":"17","author":"N Kamar","year":"2011","unstructured":"Kamar N, Bendall RP, Peron JM et al (2011) Hepatitis E virus and neurologic disorders. Emerg Infect Dis 17:173\u2013179. doi:10.3201\/eid1702.100856","journal-title":"Emerg Infect Dis"},{"key":"507_CR15","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/infdis\/jit652","volume":"209","author":"S Ijaz","year":"2014","unstructured":"Ijaz S, Said B, Boxall E et al (2014) Indigenous hepatitis E in England and wales from 2003 to 2012: evidence of an emerging novel phylotype of viruses. J Infect Dis 209:1212\u20131218. doi:10.1093\/infdis\/jit652","journal-title":"J Infect Dis"},{"key":"507_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.nmni.2015.12.001","volume":"10","author":"I Kokki","year":"2016","unstructured":"Kokki I, Smith D, Simmonds P et al (2016) Hepatitis E virus is the leading cause of acute viral hepatitis in Lothian, Scotland. New Microbes New Infect 10:6\u201312. doi:10.1016\/j.nmni.2015.12.001","journal-title":"New Microbes New Infect"},{"key":"507_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/vox.12056","volume":"105","author":"A Cleland","year":"2013","unstructured":"Cleland A, Smith L, Crossan C et al (2013) Hepatitis E virus in Scottish blood donors. Vox Sang 105:283\u2013289. doi:10.1111\/vox.12056","journal-title":"Vox Sang"},{"key":"507_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.meegid.2014.01.002","volume":"22","author":"MT P\u00e9rez-Gracia","year":"2014","unstructured":"P\u00e9rez-Gracia MT, Suay B, Mateos-Lindemann ML (2014) Hepatitis E: an emerging disease. Infect Genet Evol 22:40\u201359. doi:10.1016\/j.meegid.2014.01.002","journal-title":"Infect Genet Evol"},{"key":"507_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.coviro.2015.04.003","volume":"11","author":"S Li","year":"2015","unstructured":"Li S, Zhang J, Xia N (2015) Lessons from hepatitis E vaccine design. Curr Opin Virol 11:130\u2013136. doi:10.1016\/j.coviro.2015.04.003","journal-title":"Curr Opin Virol"},{"key":"507_CR20","doi-asserted-by":"publisher","first-page":"12986","DOI":"10.1073\/pnas.0903699106","volume":"106","author":"T Yamashita","year":"2009","unstructured":"Yamashita T, Mori Y (2009) Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. PNAS 106:12986\u201312991. doi:10.1073\/pnas.0903699106","journal-title":"PNAS"},{"key":"507_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00430-014-0346-1","volume":"203","author":"HW Doerr","year":"2014","unstructured":"Doerr HW, Berger A (2014) Vaccination against infectious diseases: what is promising? Med Microbiol Immunol 203:365\u2013371. doi:10.1007\/s00430-014-0346-1","journal-title":"Med Microbiol Immunol"},{"key":"507_CR22","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/emmm.201403876","volume":"6","author":"I Delany","year":"2014","unstructured":"Delany I, Rappuoli R, De Gregorio E (2014) Vaccines for the 21st century. EMBO Mol Med 6:708\u2013720. doi:10.1002\/emmm.201403876","journal-title":"EMBO Mol Med"},{"key":"507_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cti.2016.81","volume":"5","author":"J Sarkander","year":"2016","unstructured":"Sarkander J, Hojyo S, Tokoyoda K (2016) Vaccination to gain humoral immune memory. Clin Transl Immunol 5:1\u20136. doi:10.1038\/cti.2016.81","journal-title":"Clin Transl Immunol"},{"key":"507_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00535-012-0701-1","volume":"48","author":"Q Zhao","year":"2013","unstructured":"Zhao Q, Zhang J, Wu T et al (2013) Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy. J Gastroenterol 48:159\u2013168. doi:10.1007\/s00535-012-0701-1","journal-title":"J Gastroenterol"},{"key":"507_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00430-011-0221-2","volume":"201","author":"P Dremsek","year":"2012","unstructured":"Dremsek P, Wenzel JJ, Johne R et al (2012) Seroprevalence study in forestry workers from eastern Germany using novel genotype 3- and rat hepatitis E virus-specific immunoglobulin G ELISAs. Med Microbiol Immunol 201:189\u2013200. doi:10.1007\/s00430-011-0221-2","journal-title":"Med Microbiol Immunol"},{"key":"507_CR26","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1080\/21645515.2015.1008870","volume":"11","author":"SW Li","year":"2015","unstructured":"Li SW, Zhao Q, Wu T et al (2015) The development of a recombinant hepatitis E vaccine HEV 239. Hum Vaccines Immunother 11:908\u2013914. doi:10.1080\/21645515.2015.1008870","journal-title":"Hum Vaccines Immunother"},{"key":"507_CR27","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1056\/NEJMoa1406011","volume":"372","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zhang X-F, Huang S-J et al (2015) Long-term efficacy of a hepatitis E vaccine. N Engl J Med 372:914\u2013922. doi:10.1056\/NEJMoa1406011","journal-title":"N Engl J Med"},{"key":"507_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ebiom.2016.07.039","volume":"11","author":"H van Tong","year":"2016","unstructured":"van Tong H, Hoan NX, Wang B et al (2016) Hepatitis E virus mutations: functional and clinical relevance. EBioMedicine 11:31\u201342. doi:10.1016\/j.ebiom.2016.07.039","journal-title":"EBioMedicine"},{"key":"507_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00430-012-0283-9","volume":"202","author":"O Larralde","year":"2013","unstructured":"Larralde O, Dow B, Jarvis L et al (2013) Hepatitis B escape mutants in Scottish blood donors. Med Microbiol Immunol 202:207\u2013214. doi:10.1007\/s00430-012-0283-9","journal-title":"Med Microbiol Immunol"},{"key":"507_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311000","author":"D Todt","year":"2016","unstructured":"Todt D, Gisa A, Radonic A et al (2016) In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome. Gut. doi:10.1136\/gutjnl-2015-311000","journal-title":"Gut"},{"key":"507_CR31","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/j.1460-2075.1994.tb06501.x","volume":"13","author":"A Folgori","year":"1994","unstructured":"Folgori A, Tafi R, Meola A et al (1994) A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J 13:2236\u20132243","journal-title":"EMBO J"},{"key":"507_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jviromet.2006.10.015","volume":"140","author":"OG Larralde","year":"2007","unstructured":"Larralde OG, Martinez R, Camacho F et al (2007) Identification of hepatitis A virus mimotopes by phage display, antigenicity and immunogenicity. J Virol Methods 140:49\u201358. doi:10.1016\/j.jviromet.2006.10.015","journal-title":"J Virol Methods"},{"key":"507_CR33","doi-asserted-by":"publisher","first-page":"176172","DOI":"10.1155\/2014\/176172","volume":"2014","author":"GN Sundell","year":"2014","unstructured":"Sundell GN, Ivarsson Y (2014) Interaction analysis through proteomic phage display. Biomed Res Int 2014:176172. doi:10.1155\/2014\/176172","journal-title":"Biomed Res Int"},{"key":"507_CR34","doi-asserted-by":"publisher","first-page":"11671","DOI":"10.3748\/wjg.v20.i33.11671","volume":"20","author":"B Bakhshinejad","year":"2014","unstructured":"Bakhshinejad B, Sadeghizadeh M (2014) Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infection. World J Gastroenterol 20:11671\u201311683. doi:10.3748\/wjg.v20.i33.11671","journal-title":"World J Gastroenterol"},{"key":"507_CR35","doi-asserted-by":"publisher","first-page":"11650","DOI":"10.3748\/wjg.v20.i33.11650","volume":"20","author":"WS Tan","year":"2014","unstructured":"Tan WS, Ho KL (2014) Phage display creates innovative applications to combat hepatitis B virus. World J Gastroenterol 20:11650\u201311670. doi:10.3748\/wjg.v20.i33.11650","journal-title":"World J Gastroenterol"},{"key":"507_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00535-012-0682-0","volume":"48","author":"H Okamoto","year":"2013","unstructured":"Okamoto H (2013) Culture systems for hepatitis E virus. J Gastroenterol 48:147\u2013158. doi:10.1007\/s00535-012-0682-0","journal-title":"J Gastroenterol"},{"key":"507_CR37","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1128\/JVI.02888-12","volume":"87","author":"BC Bachler","year":"2013","unstructured":"Bachler BC, Humbert M, Palikuqi B et al (2013) Novel biopanning strategy to identify epitopes associated with vaccine protection. J Virol 87:4403\u20134416. doi:10.1128\/JVI.02888-12","journal-title":"J Virol"},{"key":"507_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jim.2006.08.006","volume":"316","author":"X Yu","year":"2006","unstructured":"Yu X, Owens GP, Gilden DH (2006) Rapid and efficient identification of epitopes\/mimotopes from random peptide libraries. J Immunol Methods 316:67\u201374. doi:10.1016\/j.jim.2006.08.006","journal-title":"J Immunol Methods"},{"key":"507_CR39","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/jmv.21656","volume":"805","author":"R Bendall","year":"2010","unstructured":"Bendall R, Ellis V, Ijaz S (2010) A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 805:799\u2013805. doi:10.1002\/jmv","journal-title":"J Med Virol"},{"key":"507_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/v8080232","volume":"8","author":"T Vollmer","year":"2016","unstructured":"Vollmer T, Diekmann J, Eberhardt M et al (2016) Monitoring of anti-hepatitis E virus antibody seroconversion in asymptomatically infected blood donors: systematic comparison of nine commercial anti-HEV IgM and IgG assays. Viruses 8:232. doi:10.3390\/v8080232","journal-title":"Viruses"},{"key":"507_CR41","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","volume":"28","author":"M Kearse","year":"2012","unstructured":"Kearse M, Moir R, Wilson A et al (2012) Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28:1647\u20131649","journal-title":"Bioinformatics"},{"key":"507_CR42","doi-asserted-by":"publisher","first-page":"101932","DOI":"10.1155\/2010\/101932","volume":"2010","author":"J Huang","year":"2010","unstructured":"Huang J, Ru B, Li S et al (2010) SAROTUP: scanner and reporter of target-unrelated peptides. J Biomed Biotechnol 2010:101932. doi:10.1155\/2010\/101932","journal-title":"J Biomed Biotechnol"},{"key":"507_CR43","doi-asserted-by":"publisher","first-page":"D271","DOI":"10.1093\/nar\/gkr922","volume":"40","author":"J Huang","year":"2012","unstructured":"Huang J, Ru B, Zhu P et al (2012) MimoDB 2.0: a mimotope database and beyond. Nucleic Acids Res 40:D271\u2013D277. doi:10.1093\/nar\/gkr922","journal-title":"Nucleic Acids Res"},{"key":"507_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/nar\/gkl975","volume":"35","author":"I Mayrose","year":"2007","unstructured":"Mayrose I, Shlomi T, Rubinstein ND et al (2007) Epitope mapping using combinatorial phage-display libraries: a graph-based algorithm. Nucleic Acids Res 35:69\u201378. doi:10.1093\/nar\/gkl975","journal-title":"Nucleic Acids Res"},{"key":"507_CR45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0022-1759(98)00177-X","volume":"221","author":"M Krook","year":"1998","unstructured":"Krook M, Mosbach K, Ramstr\u00f6m O (1998) Novel peptides binding to the Fc-portion of immunoglobulins obtained from a combinatorial phage display peptide library. J Immunol Methods 221:151\u2013157. doi:10.1016\/S0022-1759(98)00177-X","journal-title":"J Immunol Methods"},{"key":"507_CR46","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/cr.2015.34","volume":"25","author":"Y Gu","year":"2015","unstructured":"Gu Y, Tang X, Zhang X et al (2015) Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody. Cell Res 25:604\u2013620. doi:10.1038\/cr.2015.34","journal-title":"Cell Res"},{"key":"507_CR47","doi-asserted-by":"publisher","first-page":"10266","DOI":"10.1073\/pnas.1101309108","volume":"108","author":"X Tang","year":"2011","unstructured":"Tang X, Yang C, Gu Y (2011) Structural basis for the neutralization and genotype specificity of hepatitis E virus. PNAS 108:10266\u201310271. doi:10.1073\/pnas.1101309108","journal-title":"PNAS"},{"key":"507_CR48","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1016\/j.vaccine.2004.11.065","volume":"23","author":"J Zhang","year":"2005","unstructured":"Zhang J, Gu Y, Ge SX et al (2005) Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine 23:2881\u20132892. doi:10.1016\/j.vaccine.2004.11.065","journal-title":"Vaccine"},{"key":"507_CR49","doi-asserted-by":"publisher","first-page":"O397","DOI":"10.1111\/1469-0691.12419","volume":"20","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhang X-F, Zhou C et al (2014) Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity. Clin Microbiol Infect 20:O397\u2013O405. doi:10.1111\/1469-0691.12419","journal-title":"Clin Microbiol Infect"},{"key":"507_CR50","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/molecules16010790","volume":"16","author":"M Vodnik","year":"2011","unstructured":"Vodnik M, Zager U, Strukelj B, Lunder M (2011) Phage display: selecting straws instead of a needle from a haystack. Molecules 16:790\u2013817. doi:10.3390\/molecules16010790","journal-title":"Molecules"},{"key":"507_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1006\/biol.2001.0315","volume":"30","author":"M Ferguson","year":"2002","unstructured":"Ferguson M, Walker D, Mast E, Fields H (2002) Report of a collaborative study to assess the suitability of a reference reagent for antibodies to hepatitis E virus. Biologicals 30:43\u201348. doi:10.1006\/biol.2001.0315","journal-title":"Biologicals"},{"key":"507_CR52","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jcv.2013.10.003","volume":"58","author":"F Abravanel","year":"2013","unstructured":"Abravanel F, Chapuy-Regaud S, Lhomme S et al (2013) Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J Clin Virol 58:624\u2013628. doi:10.1016\/j.jcv.2013.10.003","journal-title":"J Clin Virol"},{"key":"507_CR53","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/rmv.1719","volume":"22","author":"J Zhang","year":"2012","unstructured":"Zhang J, Li S-W, Wu T et al (2012) Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity. Rev Med Virol 22:339\u2013349. doi:10.1002\/rmv.1719","journal-title":"Rev Med Virol"},{"key":"507_CR54","doi-asserted-by":"publisher","first-page":"872431","DOI":"10.1155\/2015\/872431","volume":"2015","author":"A Ahmed","year":"2015","unstructured":"Ahmed A, Ali IA, Ghazal H et al (2015) Mystery of hepatitis e virus: recent advances in its diagnosis and management. Int J Hepatol 2015:872431. doi:10.1155\/2015\/872431","journal-title":"Int J Hepatol"},{"key":"507_CR55","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2334-12-142","volume":"12","author":"HK Park","year":"2012","unstructured":"Park HK, Jeong S-H, Kim J-W et al (2012) Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays. BMC Infect Dis 12:142. doi:10.1186\/1471-2334-12-142","journal-title":"BMC Infect Dis"},{"key":"507_CR56","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1099\/vir.0.83308-0","volume":"89","author":"S He","year":"2008","unstructured":"He S, Miao J, Zheng Z et al (2008) Putative receptor-binding sites of hepatitis E virus. J Gen Virol 89:245\u2013249. doi:10.1099\/vir.0.83308-0","journal-title":"J Gen Virol"},{"key":"507_CR57","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1128\/JVI.74.12.5548-5555.2000","volume":"74","author":"D Schofield","year":"2000","unstructured":"Schofield D, Glamann J (2000) Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J Virol 74:5548\u20135555. doi:10.1128\/JVI.74.12.5548-5555.2000","journal-title":"J Virol"},{"key":"507_CR58","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.vaccine.2003.07.008","volume":"22","author":"DJ Schofield","year":"2003","unstructured":"Schofield DJ, Purcell RH, Nguyen HT, Emerson SU (2003) Monoclonal antibodies that neutralize HEV recognize an antigenic site at the carboxyterminus of an ORF2 protein vaccine. Vaccine 22:257\u2013267. doi:10.1016\/j.vaccine.2003.07.008","journal-title":"Vaccine"},{"key":"507_CR59","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3748\/wjg.v10.i11.1583","volume":"10","author":"Y Gu","year":"2004","unstructured":"Gu Y, Zhang J, Wang YB et al (2004) Selection of a peptide mimicking neutralization epitope of hepatitis E virus with phage peptide display technology. World J Gastroenterol 10:1583\u20131588. doi:10.3748\/wjg.v10.i11.1583","journal-title":"World J Gastroenterol"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-017-0507-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-017-0507-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-017-0507-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:46:53Z","timestamp":1744174013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-017-0507-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,22]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["507"],"URL":"https:\/\/doi.org\/10.1007\/s00430-017-0507-0","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"type":"print","value":"0300-8584"},{"type":"electronic","value":"1432-1831"}],"subject":[],"published":{"date-parts":[[2017,4,22]]},"assertion":[{"value":"24 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All blood donors were voluntary and non-remunerated. Anonymous data was used in the study protocol in order to protect confidentiality.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}